T Cells Expressing a Novel Fully-Human Anti-BCMA CAR for Treating Multiple Myeloma
Clinical trial NCT03602612 · COMPLETED
Trial details
- NCT number
- NCT03602612
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-14
- Primary completion
- 2023-01-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.